Corporate News     07-Aug-23
Marksans' Goa unit completes USFDA's PADE inspection
With two observations
Marksans Pharma announced that the United State Food and Drug Administration (USFDA) has completed a Post-marketing Adverse Drug Experience (PADE) inspection. The inspection closed with two observations.

The inspection was conducted at its Goa, Verna manufacturing facility from 31 July 2023 to 4 August 2023. The inspection included comprehensive scrutiny of practices and procedures for reporting of adverse events of Marksans' marketed products.

The company will submit corrective and preventive action plan (CAPA) to the USFDA in the stipulated time frame.

Previous News
  Marksans Pharma arm receives UK MHRA marketing authorization for Levetiracetam Relonchem
 ( Corporate News - 28-May-24   12:08 )
  Marksans Pharma to conduct AGM
 ( Corporate News - 01-Aug-22   16:48 )
  Marksans Pharma consolidated net profit rises 31.27% in the December 2023 quarter
 ( Results - Announcements 13-Feb-24   16:31 )
  Marksans Pharma reports consolidated net profit of Rs 8.58 crore in the March 2019 quarter
 ( Results - Announcements 29-May-19   17:24 )
  Marksans Pharma gets UK MHRA approval for Fluoxetine oral solution
 ( Hot Pursuit - 23-Jan-23   13:30 )
  Marksans Pharma standalone net profit rises 45.76% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:41 )
  Marksans Pharma commences buyback of shares
 ( Corporate News - 15-Jul-22   17:50 )
  Marksans Pharma standalone net profit declines 97.28% in the June 2016 quarter
 ( Results - Announcements 14-Aug-16   10:25 )
  Marksans Pharma declines after US FDA issues Form 483 with 5 observations to Goan plant
 ( Hot Pursuit - 18-Apr-24   11:52 )
  Marksans Pharma consolidated net profit declines 8.75% in the September 2021 quarter
 ( Results - Announcements 10-Nov-21   12:11 )
  Indo Count Industries Ltd leads gainers in 'A' group
 ( Hot Pursuit - 04-Jul-18   12:00 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top